CTIS2022-501082-52-00招募中1 期
ong-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of RP-L102 - RP-L102-0221-LTF
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 64（—）
- 性别
- All
入选标准
- •Subject was enrolled in one of the RP-L102 parent studies (RP-L102-0418, RP-L102-0319, RP-L102-0118)., Subject received an autologous infusion of CD34+ enriched cells transduced ex vivo with LV vector carrying the FANCA gene, PGK-FANCA-WPRE (RP-L102), in the parent study., Subject is willing and able to adhere to the study visit schedule and other protocol requirements., Subject has provided written informed consent and, as applicable, assent to participate in the current study in accordance with current regulatory requirements.
排除标准
- •There are no exclusion criteria in this study.
研究者
相似试验
未知
4 期
Extension study following the phase I/II clinical study of CT-P13 in the patients with rheumatoid arthritisRheumatoid arthritisJPRN-jRCT1080222652ippon Kayaku Co., Ltd.
未知
1 期
Extension study following the phase I/II clinical study of CT-P13 in the patients with rheumatoid arthritisRheumatoid arthritisJPRN-jRCT2080222369ippon Kayaku Co., Ltd.
进行中（未招募）
1 期
A follow-up study in patients with moderate to severe active ulcerative colitis.Moderate to severe Ulcerative Colitis.MedDRA version: 20.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 100000004856EUCTR2017-003284-35-PLABIVAX30
进行中（未招募）
1 期
A follow-up study in patients with moderate to severe active ulcerative colitis.Moderate to severe Ulcerative Colitis.MedDRA version: 20.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 100000004856EUCTR2017-003284-35-HUABIVAX30
进行中（未招募）
1 期
Investigate the efficacy and safety of study drug ABX464 50 mg once daily in patients with moderate to severe Active Ulcerative Colitis.Moderate to severe Ulcerative Colitis.MedDRA version: 20.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 100000004856EUCTR2017-003284-35-ESABIVAX30